Assessing Causality Between Plasma Brain‐Derived Neurotrophic Factor With Major Depression Disorder: A Bidirectional Mendelian Randomization Study
Brain and Behavior · 2025
DOI: 10.1002/brb3.70425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Ming Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzho…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Major Depressive Disorder. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Health Science and Technology Project.
Themen: Depression
Abstract (Originalsprache)
Purpose
This study employed a two‐sample Mendelian randomization (MR) approach to investigate the bidirectional relationship between brain‐derived neurotrophic factor (BDNF) and major depressive disorder (MDD), addressing gaps left by prior observational studies.
Methods
We utilized Genome‐Wide Association Study (GWAS) datasets, including MDD information from the Psychiatric Genomics Consortium (PGC) and the UK Biobank ( N = 500,199), along with plasma BDNF measurements from the FinnGen Consortium ( N = 619). In a subsequent phase, we analyzed MDD data from FinnGen ( N = 448,069) with plasma BDNF data from three additional GWAS sources: UK Biobank ( N = 33,924), deCODE ( N = 35,353), and INTERVAL ( N = 3301). Multiple MR methods were applied to ensure a robust analysis.
Results
The inverse variance weighted (IVW) method revealed no significant association between plasma BDNF levels and the risk of developing MDD (IVW odds ratio [OR] = 1.00, 95% confidence interval [CI] = 0.99–1.01, p = 0.769). Similarly, no causal effect of the BDNF gene on MDD was identified (OR = 0.91, CI = 0.23–3.56, p = 0.893). Furthermore, there was no evidence supporting a causal link between MDD and plasma BDNF levels (OR = 0.99, CI = 0.89–1.09, p = 0.783). The second phase of analysis confirmed the absence of bidirectional causal relationships.
Conclusion
This bidirectional MR analysis provides no evidence of a causal association between plasma BDNF levels and MDD. These findings prompt a re‐evaluation of plasma BDNF as a biomarker for MDD and emphasize the need for further investigation into its functional role within the plasma as well as its levels and activity in the brain and cerebrospinal fluid.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Mental Health Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Department of Cardiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Hao-Zhang Huang
Förderung
- Guangzhou Health Science and Technology Project
Zitieren
APA
Chen, M., Huang, H. Z., Liu, Y. H., Li, Q., Fu, L. Y., & Hou, C. L. (2025). Assessing Causality Between Plasma Brain‐Derived Neurotrophic Factor With Major Depression Disorder: A Bidirectional Mendelian Randomization Study. Brain and Behavior. https://doi.org/10.1002/brb3.70425
Vancouver
Chen M, Huang HZ, Liu YH, Li Q, Fu LY, Hou CL. Assessing Causality Between Plasma Brain‐Derived Neurotrophic Factor With Major Depression Disorder: A Bidirectional Mendelian Randomization Study. Brain and Behavior. 2025. doi:10.1002/brb3.70425
BibTeX
@article{Chen2025,
author = {Chen, Ming and Huang, Hao-Zhang and Liu, Yi-Hui and Li, Qiang and Fu, Lin-Yan and Hou, Cai-Lan},
title = {Assessing Causality Between Plasma Brain‐Derived Neurotrophic Factor With Major Depression Disorder: A Bidirectional Mendelian Randomization Study},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70425}
}
EUVIMED